United Rheumatology Newsfeed
Registration now open for “Gaining a Payer Perspective: United Rheumatology, our Members and Payers collaborating to build value-based offerings”
ATLANTA — A daily regimen of 15 mg upadacitinib was significantly more effective than placebo in improving signs, symptoms, function and imaging among patients with active ankylosing spondylitis, according to the presenter at … Read moreUpadacitinib improves signs, symptoms in patients with active AS
In the dermatology setting, researchers found a substantial delay from symptom onset to a psoriatic arthritis diagnosis compared with rheumatology, according to LOOP, a multicenter study across 44 sites in the U.S.“This may … Read morePsA diagnosis often delayed in dermatology vs. rheumatology
The American College of Rheumatology has added the Vectra blood test, developed by Myriad Genetics, to its list of recommended disease activity measures for rheumatoid arthritis, according to a press release.“We are excited … Read moreACR adds Vectra test to recommended RA activity measures
ATLANTA — Ixekizumab combined with conventional background medication is superior to both conventional background medication alone and placebo in improving signs, symptoms and inflammation based on MRI among patients with nonradiographic axial spondyloarthritis, … Read moreIxekizumab plus background drugs bested background drugs alone in axial SpA
ATLANTA — An intervention bundle reminding patients with rheumatoid arthritis and juvenile idiopathic arthritis of the benefits of influenza vaccination was associated with improved vaccine coverage, according to findings presented at ACR/ARP 2019.Valeria … Read moreIntervention bundle improves flu vaccination rates in RA/JIA patients
This is eye-opening and important for lupus patients to know: African Americans with lupus were 18 times more likely than Caucasian patients to suffer a cardiovascular event during a 10-year period. The post … Read moreAfrican Americans with Lupus Face a Very High Risk of Heart Problems, and They Peak Close to Diagnosis
With advancements in rheumatoid arthritis medication, those with osteoarthritis may now have a higher disease burden overall. The post Osteoarthritis Patients May Have More Comorbidities Than Rheumatoid Arthritis, Study Shows appeared first on … Read moreOsteoarthritis Patients May Have More Comorbidities Than Rheumatoid Arthritis, Study Shows
Vagus nerve stimulation is being studied for its potential to help RA patients who don’t respond to medication such as biologics. Here’s what you need to know. The post Understanding Vagus Nerve Stimulation: … Read moreUnderstanding Vagus Nerve Stimulation: A New Way to Treat Rheumatoid Arthritis
The anti-malarial drug lowers cholesterol and blood sugar and makes blood less sticky, which is good for reducing blood clots and heart attack risk. The post Taking Hydroxychloroquine for RA or Lupus Can … Read moreTaking Hydroxychloroquine for RA or Lupus Can Reduce Heart Risk by 17%
“Giant cell arteritis requires ongoing management, but it does not necessarily require continuous treatment.” The post Nearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping … Read moreNearly Half of Giant Cell Arteritis Patients on Actemra for a Year Stay in Remission After Stopping It
The American Medical Association has adopted a new policy to help ensure residents and fellows who lose their jobs due to unexpected teaching hospital closures are financially and professionally protected. The organization’s new policy, adopted during … Read moreAMA takes steps to protect residents, fellows impacted by teaching hospital closures
One of the primary goals of the $10 billion project to move the Department of Veterans Affairs (VA) to a new health records system was to enable data sharing between the VA and the … Read more(Another) roadblock identified in VA, DOD transition to Cerner EHR
Senate and House lawmakers introduced a bill that would fund 1,000 additional medical residency positions in the next five years to address an anticipated physician shortage and to combat the ongoing opioid crisis.
Workers’ contributions to their health plan premiums and deductibles increased at a faster rate than wages over the past decade—with these costs accounting for an increasing share of income, according to a new … Read moreHealth plan premiums, deductibles account for an increasing piece of employee incomes: study
The Trump administration estimates to release rules on drug prices and information blocking this month but punted finalizing a rule on interoperability until 2022.
Rheumatology Advisor Newsfeed
Implementing a treat-to-target approach for the care of rheumatoid arthritis (RA) did not result in an increase in adverse events or resource use, a post-hoc analysis of a randomized trial showed. In an … Read moreTreat-to-Target in RA: No Increase in AEs
JAMA features a report on the controversy of stem cell treatments for musculoskeletal (MSK) disorders. Stem cell clinics are popular and proliferating as they are largely a cash business and fall outside of … Read moreUnproven But Profitable Stem Cell Clinics
In response to the growing opioid crisis, the US Food and Drug Administration has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS), designed to reduce the risk of abuse, misuse, … Read moreFDA's Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Finalized
The Annals of Surgery reports on an anlaysis of FDA-mandated postmarket studies, including nearly 100,000 breast implant pprocedures, that showed silicone implants to be associated with higher rates of Sjögren’s syndrome, scleroderma, rheumatoid … Read moreBreast Implant Study: More Worries or Not?